Teladoc Health Inc vs Vital Farms Inc — how do they compare? Teladoc Health Inc trades at $6.99 (market cap $1.22B), while Vital Farms Inc trades at $11.71 (market cap $494.79M). The key difference: Teladoc Health Inc is far larger — about 2.5× Vital Farms Inc's market cap, and Teladoc Health Inc is trading nearer its 52-week high, Vital Farms Inc nearer its low. Which is the better fit depends on your goals.
| TDOC | VITL | |
|---|---|---|
Market Cap | $1.22B | $494.79M |
Sector | Health | Consumer Staples |
52-Week High | $9.72 | $52.41 |
52-Week Low | $4.47 | $8.28 |
Enterprise Value | $1.48B | $581.79M |
Signals from Pluang's Aura AI — not financial advice
Teladoc Health (TDOC) trades at $6.96, up 2.2% today, but remains under pressure following a sharp 28% drop after its Q2 2026 revenue miss and lowered full-year guidance. The stock shows a bearish technical trend, with negative profitability metrics and a net loss of $200.32 million in 2025. Recent news is dominated by multiple law firm investigations into potential securities claims, adding to investor uncertainty despite some earnings beats in recent quarters.
The outlook is cautious. While valuation ratios like P/S of 0.48 and EV/EBITDA of 6.88 appear attractive, persistent net losses and the recent guidance cut signal fundamental challenges. The primary investment opportunity lies in a potential turnaround if cost controls and growth in Integrated Care stabilize results, but risks from ongoing legal probes and competitive pressures in virtual care are significant headwinds for shareholders.
Vital Farms (VITL) trades at $11.52, down 0.35% with bearish technical signals. The company reported mixed Q2 2026 results with a loss of $0.47 per share but beat revenue estimates amid industry oversupply challenges. Financials show declining profitability with net margin at 0.02% in 2026 versus 8.72% in 2025, though valuation ratios like P/E of 11.77 and P/S of 0.67 appear reasonable. Recent news highlights a $125 million term loan financing and ongoing operational headwinds.
The outlook remains cautious with analyst consensus bullish (56% buy ratings) and a $13.00 price target suggesting 13% upside. Key risks include execution amid industry oversupply, cost pressures, and volatile earnings. The stock's current technical weakness near support levels may present entry opportunities for patient investors betting on a fundamental recovery.
Trailing returns across standard periods
Latest headlines on both assets
Teladoc Health is a virtual health provider with a telehealth platform delivering 24-hour, on-demand healthcare via mobile devices, the internet, video, and phone. It also offers remote patient monitoring programs for chronic care management. Its platform connects members with a network of physicians and behavioral health professionals. Most of the company's revenue is generated from access fees on a subscription basis (per member, per month). The balance comes from visit fees and equipment rental and sales to hospital systems. Since inception, Teladoc has primarily partnered with employers, health plans, and health systems to offer network access to their members.
Read more on TDOC →Vital Farms is a leading provider of ethically produced, pasture-raised eggs and butter in the United States. Operating as a Public Benefit Corporation, it manages a network of over 650 family farms to deliver high-welfare food products. It leverages a scalable 'asset-light' partnership model that prioritizes transparency and animal welfare to meet the growing consumer demand for clean-label and sustainable food sources.
Read more on VITL →